相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia
Bin Zhang et al.
NATURE MEDICINE (2018)
Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells
Mengjie Rui et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Long non-coding RNAs in anti-cancer drug resistance
Qin-nan Chen et al.
ONCOTARGET (2017)
Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231
Hamidreza Moazzeni et al.
MOLECULAR AND CELLULAR PROBES (2017)
Influence of microRNAs and Long Non-Coding RNAs in Cancer Chemoresistance
Duncan Ayers et al.
GENES (2017)
Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer
Zhi Ling Teo et al.
CANCER RESEARCH (2017)
被撤回的出版物: Protective Effects of MicroRNA-126 on Human Cardiac Microvascular Endothelial Cells Against Hypoxia/Reoxygenation-Induced Injury and Inflammatory Response by Activating PI3K/Akt/eNOS Signaling Pathway (Retracted article. See vol. 57, pg. 309, 2023)
Hong-Hui Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
MiR-126 inhibits vascular endothelial cell apoptosis through targeting PI3K/Akt signaling
Lingqiang Chen et al.
ANNALS OF HEMATOLOGY (2016)
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells
Eric R. Lechman et al.
CANCER CELL (2016)
microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway
Jie Gao et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)
MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell
Jingwen Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Aberrant expression of miR-9 in benign and malignant breast tumors
Aisan Hasanzadeh et al.
MOLECULAR AND CELLULAR PROBES (2016)
Clinical implications of the intrinsic molecular subtypes of breast cancer
Aleix Prat et al.
BREAST (2015)
A global microRNA screen identifies regulators of the ErbB receptor signaling network
Annabell Bischoff et al.
CELL COMMUNICATION AND SIGNALING (2015)
Targeting Of miR9/NOTCH1 Interaction Reduces Metastatic Behavior in Triple-negative Breast Cancer
Samira Mohammadi-Yeganeh et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
The Role of MicroRNAs in the Chemoresistance of Breast Cancer
Jing Wang et al.
DRUG DEVELOPMENT RESEARCH (2015)
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory
Melina Arnold et al.
EUROPEAN JOURNAL OF CANCER (2015)
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
Gloria Bertoli et al.
THERANOSTICS (2015)
MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer
Jae Moon Gwak et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors
Sadhna R. Vora et al.
CANCER CELL (2014)
miR-205 and miR-200c: Predictive Micro RNAs for Lymph Node Metastasis in Triple Negative Breast Cancer
Ufuk Berber et al.
JOURNAL OF BREAST CANCER (2014)
Pluripotent Stem Cell miRNAs and Metastasis in Invasive Breast Cancer
Stefano Volinia et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis
Xiaojun Li et al.
MEDICAL ONCOLOGY (2014)
MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2)
Xuyang Jiao et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Overexpressions of MicroRNA-9 and MicroRNA-200c in Human Breast Cancers Are Associated with Lymph Node Metastasis
Jincai Wang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Oncogenic miR-181a/b afect the DNA damage response in aggressive breast cancer
Andrea Bisso et al.
CELL CYCLE (2013)
The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells
Ying Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
TGF-beta upregulates miR-181a expression to promote breast cancer metastasis
Molly A. Taylor et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
The shaping and functional consequences of the microRNA landscape in breast cancer
Heidi Dvinge et al.
NATURE (2013)
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013
Jing Wang et al.
NUCLEIC ACIDS RESEARCH (2013)
Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer
Stefano Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
MicroRNA Expression Signatures in Solid Malignancies
Marco Galasso et al.
CANCER JOURNAL (2012)
Attenuation of miR-126 Activity Expands HSC In Vivo without Exhaustion
Eric R. Lechman et al.
CELL STEM CELL (2012)
MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival
Wei Tang et al.
PLOS ONE (2012)
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
Stefano Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2
Ni Zhu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer
Francoise Rothe et al.
PLOS ONE (2011)
MicroRNA-mediated drug resistance in breast cancer
Kristy R. Kutanzi et al.
CLINICAL EPIGENETICS (2011)
Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
Zhongxing Liang et al.
BIOCHEMICAL PHARMACOLOGY (2010)
A MicroRNA Targeting Dicer for Metastasis Control
Graziano Martello et al.
CELL (2010)
Reprogramming of miRNA networks in cancer and leukemia
Stefano Volinia et al.
GENOME RESEARCH (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
The cell growth suppressor, mir-126, targets IRS-1
Jin Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer
U. Lehmann et al.
JOURNAL OF PATHOLOGY (2008)
Molecular origins of cancer: Oncogenes and cancer
Carlo M. Croce
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
John A. Foekens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies
Michael D. Mattie et al.
MOLECULAR CANCER (2006)
Mammalian cyclin-dependent kinases
M Malumbres et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Identification of novel genes coding for small expressed RNAs
M Lagos-Quintana et al.
SCIENCE (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
